Αρχική World News Breast Cancer Survivor Says Mistletoe Injections Have Kept Her Cancer-Free For Five...

Breast Cancer Survivor Says Mistletoe Injections Have Kept Her Cancer-Free For Five Years

Ali Bayliss is a breast cancer survivor who credits a rather unusual therapy for staying cancer-free: mistletoe injections.When Bayliss was diagnosed in 2014, she was only in her mid-40s. She underwent a mastectomy on the affected breast and reconstruction. Beyond that, however, she refused all other treatments offered to her, saying that her “weak body couldn’t cope.”Bayliss had been diagnosed with multiple sclerosis (MS), a few years earlier, a condition where the body’s own immune system attacks nerve coverings and damages them, leading to brain and spinal deterioration and potential disruption to a variety of bodily functions.Photo: Adobe Stock/natagolubnycha
Just because she didn’t want to utilize therapies like chemo or radiation didn’t mean Bayliss was eschewing all treatment, however. She was interested in trying alternative therapies that would be less harsh on her body.So when her husband, Mike, heard about mistletoe injections and suggested it to Bayliss, she was game to try them.Photo: Facebook/Ali Bayliss
“People think mistletoe is just for Christmas but for me it’s a year round thing,” she said. “They’re always really shocked that I use it to treat my cancer as I think to most people it’s just something to kiss under during the festive season.”Mistletoe extract is made from the semi-parasitic plant that attaches to trees like pine, oak, and apple. The treatment is typically given via injection just underneath the surface of the skin. It can also be taken orally, or injected into into a vein, pleural cavity, or the tumor itself, though all of these methods are far less common.Photo: Facebook/Ali Bayliss
In the U.S., mistletoe has not been approved by the FDA as a treatment for any medical condition. It has also not been approved in the U.K. However, across Europe, mistletoe treatments are quite common — in fact, mistletoe extract is one of the most prescribed drugs to cancer patients, according to cancer.gov.Mistletoe is one of the most studied alternative medicines out there. However, it is important to note that it is mostly given as an adjuvant therapy, in addition to other treatment, rather than a standalone therapy.Photo: Facebook/Ali Bayliss
“The mistletoe has hugely improved my immune system, it has no side effects, in fact I feel nothing when I take it but I’ve not had a cold for years,” she said.Bayliss has a consultant in Germany, and she orders the injections from there.However, Bayliss has taken control of her health in other ways, too. She doesn’t eat processed foods, meat or dairy, and instead eats a lot of colorful fruits and vegetables.Photo: Facebook/Ali Bayliss
Bayliss says her husband has been amazing through all of her health issues.“I firmly believe that I’d be dead without him and my mistletoe,” she said.Source

Προηγούμενο άρθροProstate Cancer
Επόμενο άρθροSurgery for Recurrent Ovarian Cancer Does Not Improve Survival

NEWSLETTER

Συμπληρώστε το email σας για να λαμβάνετε τις σημαντικότερες ειδήσεις από το ogkologos.com

Βρείτε μας

2,449ΥποστηρικτέςΚάντε Like
57ΑκόλουθοιΑκολουθήστε

Διαβαστε Επίσης

Καρκίνος και Κορωνοϊός (COVID-19) ΜΕΡΟΣ Α

Εάν είστε καρκινοπαθής, το ανοσοποιητικό σας σύστημα μπορεί να μην είναι τόσο ισχυρό όσο κανονικά, έτσι μπορεί να ανησυχείτε για τους κινδύνους που σχετίζονται...

ΠΑΓΚΟΣΜΙΑ ΗΜΕΡΑ ΚΑΡΚΙΝΟΥ

Η Παγκόσμια Ημέρα Κατά του Καρκίνου καθιερώθηκε με πρωτοβουλία της Διεθνούς Ένωσης κατά του Καρκίνου (UICC), που εκπροσωπεί 800 οργανώσεις σε 155 χώρες του...

ΕΞΕΛΙΞΕΙΣ ΣΤΗ ΘΕΡΑΠΕΙΑ ΤΟΥ ΜΗ-ΜΙΚΡΟΚΥΤΤΑΡΙΚΟΥ ΚΑΡΚΙΝΟΥ ΤΟΥ ΠΝΕΥΜΟΝΑ (ΜΜΚΠ)

ΕΞΕΛΙΞΕΙΣ ΣΤΗ ΘΕΡΑΠΕΙΑ ΤΟΥ ΜΗ-ΜΙΚΡΟΚΥΤΤΑΡΙΚΟΥ ΚΑΡΚΙΝΟΥ ΤΟΥ ΠΝΕΥΜΟΝΑ (ΜΜΚΠ) Γράφει ο Δρ Παπαδούρης Σάββας, Παθόλογος-Ογκολόγος   Ο ΜΜΚΠ βρίσκεται αναλογικά στο 80% και πλέον του συνολικού...

Διατρέχουν όντως οι καρκινοπαθείς μεγαλύτερο κίνδυνο λόγω κοροναϊού;

Σε πρακτικό επίπεδο, τα δεδομένα των σχετικών μελετών υποδηλώνουν ότι η χημειοθεραπεία ή οι άλλες αντι-νεοπλασματικές θεραπείες δεν αυξάνουν σημαντικά τον κίνδυνο θνησιμότητας από...

FDA: Η ακτινοβολία των smartphones δεν προκαλεί καρκίνο

Σε μια νέα έκθεσή της, η Υπηρεσία Τροφίμων και Φαρμάκων (FDA) των ΗΠΑ αναφέρει ότι επανεξέτασε τις σχετικές επιστημονικές έρευνες που δημοσιεύθηκαν τα τελευταία...

Νέα ανακάλυψη, νέα ελπίδα για τον καρκίνο

Ένα νεοανακαλυφθέν τμήμα του ανοσοποιητικού μας συστήματος θα μπορούσε να αξιοποιηθεί για την αντιμετώπιση όλων των ειδών καρκίνου, σύμφωνα με επιστήμονες του πανεπιστημίου Cardiff...
- Advertisment -

Ροή Ειδήσεων

Overall Breast Cancer Incidence Down Since 1999, Rates Increase for Women Under 40

U.S. breast cancer death rates decreased by about 1% per year between 2013 and 2018. What were the new case rates during that same...

Impressive Responses to PD-1 Blockade in a Large Cohort of Children and Young Adults with Recurrent/Progressive Germline DNA Replication Repair-Deficient Cancers

A large, observational, registry-based study that leveraged systematically collected data gathered both retrospectively and prospectively through the International Replication Repair Deficiency Consortium reveals impressive...

2-Year-Boy Is So Excited To See Himself In Disney’s ‘Encanto’

The importance of representation in media has been a growing topic of concern, and companies have responded by adding more diversity to their characters,...

Man Walks Entire Continent To Spread Awareness About Mental Health & Suicide Prevention

Matthew Fennell is walking over 3,000 miles across Australia for an important cause and one that is near and dear to his heart. Last year,...

Boy Battling Cancer Becomes Honorary Police Officer, Sworn In To 45 Agencies

At just ten years old, Devarjaye “DJ” Daniel has already been through more than most people go through in their entire lives. DJ has been...

Paclitaxel and Carboplatin Not Inferior When Compared with Paclitaxel and Ifosfamide for the Treatment of Patients with Uterine Carcinosarcoma

With regard to overall survival (OS), paclitaxel and carboplatin was not inferior and demonstrated improved progression-free survival (PFS) when compared with paclitaxel and ifosfamide...